Dr. Roger Steinert offers his insights on the recent European Society of Cataract & Refractive Surgeons meeting. What are the anticipated latest advances and developments?
CMS Administrator Donald M. Berwick, MD, MPP, and Richard J. Gilfillan, MD, Acting Director, Center for Medicare and Medicaid Innovation, discuss the final ACO rules and how they will affect doctors.
Dr. Steve Charles takes you on a whirlwind tour of the latest developments in vitreoretinal surgery presented at AAO this year.
ROP was a hot topic at this year's AAO. Dr. Monte Mills reviews key data on the use of bevacizumab for this significant complication of prematurity.
Experts in glaucoma discuss news from AAO that could change clinical practice.
At what point should you consult with an ophthalmologist when a patient has candidemia? Paul G. Auwaerter, MD, describes a recent study that sheds light on this topic.
Considerable interest surrounds microincision glaucoma surgery (MIGS), with its less invasive approach. Dr. Roger Steinert explores the surgical techniques and comments on their impact on practice.
Dr. Monte Mills takes a quick tour of the most interesting topics from this year's American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting in San Antonio.
With even the Supreme Court weighing in on generic vs brand-name drugs, Dr. Roger Steinert offers his opinion on this ongoing debate and what it means for practicing ophthalmologists.
Primary care providers must promptly recognize this rare condition and refer promptly in order to preserve vision in affected infants.